Prognostic Value of Trop‐2 Expression in Nonmetastatic Triple‐Negative Breast Cancer and Correlation With Emerging Biomarkers

Prognostic Value of Trop‐2 Expression in Nonmetastatic Triple‐Negative Breast Cancer and Correlation With Emerging Biomarkers

ABSTRACT Introduction Triple‐Negative Breast Cancer (TNBC) is an aggressive breast cancer subtype, in which targeting the Trophoblast cell‐surface antigen‐2 (Trop‐2), using antibody‐drug conjugates (ADC), results in significant clinical improvement. However, clinicopathological correlations with Tro...

Full description

Saved in:
Bibliographic Details
Main Authors: William Jacot, Marie‐Christine Chateau, Simon Thezenas, Séverine Guiu, Nelly Firmin, Virginie Lafont, Gwendal Lazennec, Charles Theillet, Florence Boissière‐Michot
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:Cancer Medicine
Subjects:
basal‐like
expression
molecular apocrine
prognosis
triple‐negative breast cancer
Trop‐2
Online Access:https://doi.org/10.1002/cam4.70615
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items